OTCMKTS:INBP Integrated BioPharma (INBP) Stock Price, News & Analysis $0.18 0.00 (0.00%) As of 06/5/2026 03:51 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Integrated BioPharma Stock (OTCMKTS:INBP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Integrated BioPharma alerts:Sign Up Key Stats Today's Range$0.17▼$0.1950-Day Range$0.18▼$0.3052-Week Range$0.17▼$0.42Volume17,270 shsAverage Volume8,562 shsMarket Capitalization$5.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Read More Receive INBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INBP Stock News HeadlinesIntegrated BioPharma, Inc.: Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025February 11, 2026 | finanznachrichten.deIntegrated BioPharma Holds 2025 Annual Stockholder MeetingDecember 10, 2025 | theglobeandmail.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.June 8 at 1:00 AM | Brownstone Research (Ad)Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutionsDecember 2, 2025 | globenewswire.comINBP Integrated BioPharma, Inc.June 15, 2025 | seekingalpha.comIntegrated BioPharma Secures New Credit Line with PNCApril 21, 2025 | tipranks.comIntegrated Biopharma Inc (INBP)August 31, 2024 | investing.comIntegrated BioPharma, Inc. (INBP)July 19, 2024 | finance.yahoo.comSee More Headlines INBP Stock Analysis - Frequently Asked Questions How have INBP shares performed this year? Integrated BioPharma's stock was trading at $0.3550 at the start of the year. Since then, INBP stock has decreased by 49.1% and is now trading at $0.1807. How were Integrated BioPharma's earnings last quarter? Integrated BioPharma Inc. (OTCMKTS:INBP) issued its quarterly earnings results on Friday, May, 8th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business earned $10.11 million during the quarter. Integrated BioPharma had a negative net margin of 3.43% and a negative trailing twelve-month return on equity of 8.32%. How do I buy shares of Integrated BioPharma? Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Integrated BioPharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), ExxonMobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP). Company Calendar Last Earnings5/08/2026Today6/08/2026Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:INBP CIK1016504 Webwww.integratedbiopharma.com Phone(973) 926-0816Fax973-926-1735Employees150Year Founded1995Profitability EPS (Trailing Twelve Months)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$810 thousand Net Margins-3.43% Pretax Margin-2.32% Return on Equity-8.32% Return on Assets-6.57% Debt Debt-to-Equity RatioN/A Current Ratio3.25 Quick Ratio1.78 Sales & Book Value Annual Sales$54.35 million Price / Sales0.10 Cash Flow$0.07 per share Price / Cash Flow2.69 Book Value$0.66 per share Price / Book0.27Miscellaneous Outstanding Shares30,980,000Free Float10,098,000Market Cap$5.60 million OptionableNot Optionable Beta0.35 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:INBP) was last updated on 6/8/2026 by MarketBeat.com Staff. From Our PartnersAmerica's AI Future Needs a Domestic Fuel ChainAI dominance requires power at a scale most investors have not priced in - and nuclear energy is emerging as a...i2i Marketing Group, LLC | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredNot much time left. See why this Former CIA Economistsays investors may be missing this opportunity:Institutions hear first. Insiders position early. By the time ordinary investors get access, the best part of ...The Oxford Club | SponsoredBNZI Breakout Watch: AI Growth Meets Turnaround Setup!Banzai International (NASDAQ: BNZI) posted full-year 2025 revenue of $12.2 million, up 169% year-over-year, wi...Huge Alerts | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredThe "hidden" half of the SpaceX IPOMost investors are focused on the SpaceX IPO - but the bigger opportunity may lie elsewhere. On Feb. 2, Elon M...Weiss Ratings | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
